SCHEMBL22855158

SCHEMBL22855158

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5cccc6oc7cc(-c8ccccc8)ccc7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 2/20 0.39
▸ PGR P06401 1/20 0.38
▸ ESR1 P03372 2/20 0.36
▸ ESR2 Q92731 2/20 0.36
▸ HSD17B1 P14061 3/20 0.36
▸ HSD17B2 P37059 3/20 0.36
▸ GPR84 Q9NQS5 2/20 0.36
▸ MMP12 P39900 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2B6 P20813 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29306832 0.99 HCRTR1 (0.38) HCRTR1PGRESR1ESR2HSD17B1
SCHEMBL24715242 0.97 HCRTR1 (0.38) HCRTR1PGRESR1ESR2HSD17B1
SCHEMBL27010153 0.96 HCRTR1 (0.37) HCRTR1PGRESR1ESR2HSD17B1
SCHEMBL21131860 0.95 HCRTR1 (0.38) HCRTR1PGRESR1ESR2HSD17B1
SCHEMBL20363671 0.95 PGR (0.40) HCRTR1PGRESR1ESR2HSD17B1
SCHEMBL20109983 0.94 HCRTR1 (0.38) HCRTR1PGRESR1ESR2HSD17B1
SCHEMBL23427654 0.94 GPR84 (0.37) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL23428153 0.94 GPR84 (0.37) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL23427214 0.93 PLA2G2A (0.40) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL26239625 0.93 PLA2G2A (0.40) HCRTR1HSD17B1HSD17B2MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 — — US disclosed
US-20210143344-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-05-13 — — US disclosed
US-20200411771-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2020-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 HCRTR1 3958/4885PGR 2165/4885ESR1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback